Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Daito Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is June - May.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 20, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Market Capitalization	39,089	29,536	34,043	33,086	37,154	44,980
Market Cap Growth	12.81%	-13.24%	2.89%	-10.95%	-17.40%	-21.02%
Enterprise Value	47,442	37,736	37,799	34,956	37,065	46,116
Last Close Price	1350.00	969.83	1058.51	967.02	1072.91	1314.78
PE Ratio	13.57	15.48	10.33	9.19	7.96	10.59
Forward PE	14.97	15.15	8.98	9.39	8.00	10.05
PS Ratio	0.77	0.58	0.73	0.73	0.86	0.92
PB Ratio	0.75	0.57	0.65	0.65	0.78	1.07
P/TBV Ratio	0.76	0.57	0.66	0.66	0.79	1.09
P/OCF Ratio	-	5.01	6.57	7.96	8.50	8.68
EV/Sales Ratio	0.93	0.75	0.81	0.78	0.85	0.95
EV/EBITDA Ratio	-	5.43	5.00	3.85	3.75	5.08
EV/EBIT Ratio	13.20	14.40	9.71	6.71	5.64	7.80
Debt / Equity Ratio	0.19	0.23	0.17	0.10	0.07	0.08
Debt / EBITDA Ratio	-	1.71	1.15	0.55	0.35	0.37
Net Debt / Equity Ratio	0.16	0.19	0.12	0.03	-0.02	0
Net Debt / EBITDA Ratio	-	1.39	0.79	0.15	-0.09	0.00
Net Debt / FCF Ratio	-	-10.85	-5.77	-1.00	3.63	-0.02
Asset Turnover	0.67	0.65	0.63	0.67	0.71	0.87
Inventory Turnover	2.12	2.14	1.89	1.98	1.97	2.72
Quick Ratio	1.26	1.32	1.05	1.38	1.46	1.26
Current Ratio	2.50	2.45	2.24	2.64	2.70	2.52
Return on Equity (ROE)	5.66%	3.38%	6.16%	7.15%	10.33%	10.55%
Return on Assets (ROA)	2.89%	2.10%	3.28%	4.81%	6.69%	6.60%
Return on Invested Capital (ROIC)	4.45%	2.61%	5.31%	7.31%	10.20%	10.62%
Return on Capital Employed (ROCE)	5.90%	4.30%	6.60%	9.50%	12.90%	13.20%
Earnings Yield	7.57%	6.46%	9.68%	10.88%	12.56%	9.44%
FCF Yield	-	-3.02%	-3.05%	-4.08%	-0.69%	-2.53%
Dividend Yield	2.95%	3.61%	2.83%	2.82%	2.12%	1.59%
Payout Ratio	-	52.31%	27.53%	25.86%	14.14%	15.50%
Buyback Yield / Dilution	1.83%	3.06%	0.86%	-3.38%	-1.94%	-6.42%
Total Shareholder Return	4.78%	6.67%	3.70%	-0.56%	0.18%	-4.83%

Updated Feb 28, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.